Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection.

Front Cell Infect Microbiol

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.

Published: July 2023

[This corrects the article DOI: 10.3389/fcimb.2022.847539.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402635PMC
http://dx.doi.org/10.3389/fcimb.2023.1253110DOI Listing

Publication Analysis

Top Keywords

corrigendum novel
4
novel molecular
4
molecular therapeutics
4
therapeutics targeting
4
targeting signaling
4
signaling pathway
4
pathway control
4
control hepatitis
4
hepatitis viral
4
viral infection
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!